Matrix metalloproteinase inhibitors for treatment of cancer

被引：27

作者：

Skiles, JW ^{[1
]}

Monovich, LG ^{[1
]}

Jeng, AY ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Summit, NJ 07901 USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35 | 2000年 / 35卷

关键词：

D O I：

10.1016/S0065-7743(00)35016-3

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：167 / 176

页数：10

共 71 条

[1]

ALBRIGHT JD, 1999, Patent No. 37625

[2]

ALPEGIANI M, Patent No. 02510

[3]

[Anonymous], 1999, US Patent No, Patent No. [5985900 A, 5985900]

[4]

[Anonymous], ANN REP MED CHEM

[5]

AUTIOHARMAINEN H, 1993, LAB INVEST, V69, P312

[6] Molecular recognition of protein-ligand complexes: Applications to drug design [J].

Babine, RE ;

Bender, SL .

CHEMICAL REVIEWS, 1997, 97 (05) :1359-1472

[7] Recent advances in matrix metalloproteinase inhibitor research [J].

Beckett, RP ;

Davidson, AH ;

Drummond, AH ;

Huxley, P ;

Whittaker, M .

DRUG DISCOVERY TODAY, 1996, 1 (01) :16-26

[8] Matrix metalloproteinase inhibitors 1998 [J].

Beckett, RP ;

Whittaker, M .

EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (03) :259-282

[9]

BECKETT RP, Patent No. 17655

[10]

BENDER SL, 1997, 214 NAT M AM CHEM SO

← 1 2 3 4 5 6 7 8 →